Onkure Therapeutics, Inc. · NASDAQ:OKUR
The Vanguard Group reported a 5.58% stake in Onkure Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Jan 31, 2025
The Vanguard Group reported a 5.58% stake in Onkure Therapeutics, Inc., 706,733 shares, as a passive investor on Dec 31, 2024. Filed Jan 31, 2025 (Schedule 13G).
- Stake
- 5.58%
- Shares
- 706,733
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.58% | 706,733 |
Source
Related
- Onkure Therapeutics, Inc.
- The Vanguard Group
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Jan 30, 2026
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026